{"id":48600,"date":"2022-09-20T18:02:13","date_gmt":"2022-09-20T16:02:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-blood-dialyzer-market-report-2022-increased-prevalence-of-kidney-disease-fueling-growth-researchandmarkets-com\/"},"modified":"2022-09-20T18:02:13","modified_gmt":"2022-09-20T16:02:13","slug":"global-blood-dialyzer-market-report-2022-increased-prevalence-of-kidney-disease-fueling-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-blood-dialyzer-market-report-2022-increased-prevalence-of-kidney-disease-fueling-growth-researchandmarkets-com\/","title":{"rendered":"Global Blood Dialyzer Market Report 2022: Increased Prevalence of Kidney Disease Fueling Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Blood Dialyzer Market, by Product Type, by Dialysis Membrane Material, by End User, and by Region -Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nBlood dialyzer, also known as hemodialyzer or artificial kidney, is a device used to filter blood of a person who is suffering from kidney damage. Hemodialyzer accomplishes extracorporeal removal of waste products such as creatinine, urea, and free water from the blood in states of kidney failure.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nPrevalence of kidney diseases is increasing globally, due to rising geriatric population, urinary disorders, and changing lifestyles. For instance in May 2018, According to United Nations, Department of Economic and Social Affairs, Population Division, 55% of the world’s population lived in urban areas, a proportion that is expected to increase to 68% by 2050, the world’s population could add another 2.5 billion people to urban areas by 2050, with close to 90% of this increase taking place in Asia and Africa, which had influenced favourably for sustained growth of the blood dialyzer market over the next decade.\n<\/p>\n

\nFurthermore, National Kidney Foundation 2021, published a report based on 2018 data which estimated that 1 in 3 adults in the U.S. (approximately 80 million) were at risk for kidney disease. Whereas Kidney disease affects an estimated 37 million people in the U.S. (15% of the adult population; more than 1 in 7 adults).\n<\/p>\n

\nRising geriatric population and increased prevalence of chronic kidney diseases will lead to increasing demand for blood dialyzers in the global market. For instance, according to the reports published in Centers for Disease Control and Prevention 2021 report, More than 1 in 7, that is 15% of U.S. adults or 37 million people, are estimated to have chronic kidney disease. (CKD), CKD is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%).\n<\/p>\n

\nKey features of the study:<\/strong>\n<\/p>\n